Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 6 results.
User Information
Export Records
  1. 1.   Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2-specific T Cells
  2. Singh, V.; Ji, Q. Y.; Feigenbaum, L.; Leighty, R. M.; Hurwitz, A. A.
  3. Journal of Immunotherapy. 2009 32(2): 129-139.
  1. 2.   Phenotype and functional characterization of long-term gp100-specific memory CD8(+) T cells in disease-free melanoma patients before and after boosting immunization
  2. Walker, E. B.; Haley, D.; Petrausch, U.; Floyd, K.; Miller, W.; Sanjuan, N.; Alvord, G.; Fox, B. A.; Urba, W. J.
  3. Clinical Cancer Research. 2008 14(16): 5270-5283.
  1. 3.   Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer
  2. Anderson, M. J.; Shafer-Weaver, K.; Greenberg, N. M.; Hurwitz, A. A.
  3. Journal of Immunology. 2007, Feb; 178(3): 1268-1276.
  1. 4.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 5.   Autoantigens act as tissue-specific chemoattractants
  2. Oppenheim, J. J.; Dong, H. F.; Plotz, P.; Caspi, R. R.; Dykstra, M.; Pierce, S.; Martin, R.; Carlos, C.; Finn, O.; Koul, O.; Howard, O. M. Z.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 854-861.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel